Adipose Tissue Complexities in Dyslipidemias
, 2019 Adipose tissue is the largest organ in the human body and, in excess, contributes to dyslipidemias and the dysregulation of other vascular and metabolic processes.
Deborah R. Gustafson +1 more
core +1 more source
ChildrenFamilial hypercholesterolemia (FH) is a common genetic disorder with a fairly constant worldwide prevalence of 1 case per 311 individuals worldwide.
Maria Elena Capra +5 more
doaj +1 more source
Correlation of hypothyroidism and dyslipidemias with plantar fasciitis in Indian population [PDF]
, 2023 Background: Plantar fasciitis (PF) affects millions of people but still there is lack of knowledge of all the factors involved in causing this condition.
Sanjay Kantharia +15 more
core +1 more source
Fatores nutricionais associados às dislipidemias em usuários de serviço de atenção primária à saúde.
Acta Médica Portuguesa, 2011 Dyslipidemias are relevant to public health because are one of the major risk factors for Non-Communicable Diseases and Disorders, especially cardiovascular diseases.Identify factors associated with dyslipidemias on users of Primary Health Care Center ...
Nathália Luíza Ferreira +3 more
doaj +1 more source
The Journal of Clinical Endocrinology & Metabolism, 2007 Recently, considerable progress has been made in understanding the genetic basis of dyslipidemias and in studying the safety and efficacy of lipid-lowering drugs for coronary heart disease (CHD) prevention. Novel loci have been identified for monogenic hypercholesterolemia, such as low-density lipoprotein (LDL) receptor (LDLR)-associated protein ...
Abhimanyu, Garg, Vinaya, Simha
openaire +2 more sources
Diet and Lipid-Lowering Nutraceuticals in Pediatric Patients with Familial Hypercholesterolemia
ChildrenFamilial hypercholesterolemia is a genetically determined disease characterized by elevated plasma total and LDL cholesterol levels from the very first years of life, leading to early atherosclerosis. Nutritional intervention is the first-line treatment,
Maria Elena Capra +4 more
doaj +1 more source
Atherogenic Dyslipidemias: Unmet Needs and the Therapeutic Potential of Emerging and Novel Approaches and Drugs [PDF]
, 2023 Innovative lipid-modifying agents are valuable resources to improve the control of atherogenic dyslipidemias and reduce the lipid-related residual cardiovascular risk of patients with intolerance or who are not fully responsive to a consolidated standard
Stefano Genovese +6 more
core +1 more source
Frequency of Dyslipidemia In Type 2 Diabetic Patients In Karachi
Journal of Bahria University Medical and Dental College, 2019 Objective: To find out the frequency of dyslipidemias in type 2 diabetic patients. Study Design and Setting: This was cross-sectional study and conducted in a different clinics in Karachi during 3 months period. Methodology: Those patients who fulfilled
Sehrish Shafique +4 more
doaj +1 more source
Long-term effects of ambient air pollutants to blood lipids and dyslipidemias in a Chinese rural population [PDF]
, 2019 Both air pollution and dyslipidemias contributed to large number of deaths and disability-adjusted life lost years. Long-term air pollution exposure was related to changed blood lipids and risk of dyslipidemias.
Liu, Yisi +10 more
core +1 more source
Risk factors for cardiovascular disease in children on chronic hemodialysis: Traditional (general) risk factors, Part I [PDF]
Vojnosanitetski Pregled, 2016 nema
Šulović Ljiljana S.
doaj +1 more source